First Patient Enrolled in Diffusion Pharmaceuticals' Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke - GlobeNewswire

First Patient Enrolled in Diffusion Pharmaceuticals' Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke  GlobeNewswire

Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management